Stockholders' Equity - Summary of Non-Vested Options (Detail) - $ / shares |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
Aug. 31, 2019 |
Aug. 31, 2020 |
Aug. 31, 2019 |
|
| Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |||
| Non-vested at November 30, 2019 Shares | 125,234 | ||
| Granted, Shares | 110,965 | 51,969 | 112,465 |
| Vested, Shares | (102,626) | ||
| Non-vested at August 31, 2020, Shares | 74,577 | ||
| Non-vested at November 30, 2019, Weighted Average Grant-Date Fair Value | $ 4.70 | ||
| Granted, Weighted Average Grant-Date Fair Value | 4.94 | $ 3.32 | |
| Vested, Weighted Average Grant-Date Fair Value | 4.62 | ||
| Non-vested at August 31, 2020, Weighted Average Grant-Date Fair Value | $ 4.98 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|